# PayerIQ Documentation Readiness Demo

## Buyer Brief
- Product: PayerIQ
- Buyer: Prior authorization, revenue-cycle, utilization-management, access, and finance transformation leaders
- Agent: Documentation-Before-Authorization Agent
- Status: executable-demo
- Executable route: /documentation-before-authorization

## Objective
Demonstrate how a synthetic authorization scenario becomes a scored documentation-gap packet, reviewer queue, audit trace, and prepare-only workflow handoff.

## Synthetic Scenario
A registered synthetic authorization packet is checked against symptom, function, timing, rationale, therapy-history, evidence, policy, note, and reviewer requirements without accepting free text or payer identifiers.

## Guided Evaluation
- Choose a registered synthetic procedure-authorization scenario.
- Mark the documentation requirements represented in the packet.
- Generate the completeness score, missing-evidence list, reviewer queue, and audit hash.
- Test the payer-action path and confirm it fails closed with no transmission.

## Inspectable Proof
- [Interactive workbench](/documentation-before-authorization): Deterministic completeness scoring, missing-evidence packet, reviewer queue, value assumptions, and payer-action denial.
- [Workflow value methodology](/healthcare-value-realization): Buyer-defined baseline and claims-safe measurement rules for documentation completeness and reviewer effort.
- [Health records boundary](/health-records): No-PHI extraction, provenance, standards mapping, and live-data approval path.

## Inspectable Outcomes
- Documentation completeness score
- Missing-evidence packet
- Reviewer ownership and next actions
- Prepare-only SCRIMED Work handoff

## Success Signals
- Documentation gaps surfaced before submission
- Reviewer queue made explicit
- Evidence trace retained
- Payer-facing action blocked

## Governance Boundaries
- Registered synthetic scenarios and enumerated inputs only.
- Human review remains required for every output.
- Workflow economics remain assumptions until buyer baselines and finance review exist.

## Production Exclusions
- No live PHI or payer-member identifiers
- No medical-necessity determination
- No prior-authorization or appeal submission
- No reimbursement or denial-reduction guarantee

## Product Boundary
SCRIMED demos and pilot programs are governed synthetic evaluations for enterprise buyers. They do not ingest live PHI, diagnose, treat, submit payer transactions, contact patients, mutate production records, or autonomously execute clinical care.

This brief supports enterprise evaluation and pilot scoping. It is not clinical advice, a production authorization, a certification claim, or evidence of autonomous clinical execution.